Wood DW, Downes JJ, Scheinkopf H., et al. Intravenous isoproterenol in the management of respiratory failure in childhood status asthmaticus. J Allergy Clin Immunol1972;50:75-81.
2.
Wood DW, Downes JJIntravenous isoproterenol in the treatment of respiratory failure in childhood status asthmaticus. Ann Allergy1973;31:607-10.
3.
Steiner P., Rao M., Ehrlich R., et al. The use of intravenous isoproterenol in the treatment of status asthmaticus. J Asthma Res1975;12:215-9.
4.
Parry WH, Martorano F., Cotton EKManagement of life-threatening asthma with intravenous isoproterenol infusions . Am J Dis Child1976;130:39-42.
5.
Herman JJ, Noah ZL, Moody RRUse of intravenous isoproterenol for status asthmaticus in children . Crit Care Med1983;11:716-20.
6.
Matson JR, Loughlin GM, Strunk RCMyocardial ischemia complicating the use of isoproterenol in asthmatic children . J Pediatr1978;92:776-8.
7.
Kurland G., Williams J., Lewiston NJFatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma. J Allergy Clin Immunol1979;63:407-11.
8.
Klaustermeyer WB, Di Bernardo RL, Hale FC. Intravenous isoproterenol: rationale for bronchial asthma. J Allergy Clin Immunol1975;55:325-33.
9.
Pierce RJ, Payne CR, Williams SJ, et al. Comparison of intraveneous and inhaled terbutaline in the treatment of asthma. Chest1981;79:506-11.
10.
Williams SJ , Winner SJ, Clark Tjh.Comparison of inhaled and intravenous terbutaline in acute severe asthma. Thorax1981;36:629-31.
11.
Lofdahl CG, Marlin GE, Svedmyr N.Pafenolol, a highly selective B1-adrenoceptor-antagonist, in asthmatic patients: interaction with terbutaline. Clin Pharmacol Ther1983;33:1-9.
12.
Greefhorst Apm, van Herwaarden CLA.Ventilatory and haemodynamic effects of terbutaline infusion during beta-1 selective blockade with metoprolol and acebutolol in asthmatic patients. Eur J Clin Pharmacol1982;23:203-8.
13.
Downes JJ, Heiser M.Status asthmaticus in children. In: Gregory GA, ed. Respiratory Failure in the Child. New York: Churchill Livingstone, 1981;107.
